Loading asset research
Q2 2026 earnings · Sep 25
Lite Strategy Inc. Common Stock
LITSNasdaq · USD · StocksQuote as of · Exchange session not verified$1.11
+4.72%
Today
LITS
Loading 1D prices…
Market cap
$37.8M
Volume
278.1K
52w high
$3.0352w low
$0.69Company profile
Lite Strategy Inc. Common Stock
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
4
Fiscal year end
0630
CIK
1262104
Session & valuation
Open$1.06
Previous close$1.06
Day high$1.12
Day low$1.06
30-day avg. volume242.8K
Outstanding shares34M
Diluted EPS-$1.68
Latest annual period
P/E (trailing)-0.66
P/E (forward)—
Price / book0.69
Beta0.04
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| FLNAFilana Therapeutics Inc. Common Stock | $37.3M | $0.00 | — | -$1.88 | -4.94% | Buy |
| CRVOCervoMed Inc. Common Stock | $38.9M | $4M | -673.15% | -$2.98 | +3.63% | Buy |
| IXHLIncannex Healthcare Inc. Common Stock | $39M | $86K | -19547.67% | -$1.51 | +0.31% | Hold |
| KPTIKaryopharm Therapeutics Inc. Common Stock | $36.5M | $146.1M | -134.21% | -$17.93 | -1.23% | Buy |
| NSRXNasus Pharma Ltd. Ordinary Shares | $39.9M | $1.2B | -0.47% | -$0.72 | +1.64% | Buy |